DieffenbachCW, FauciAS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA, 2009; 301:2380–2382.
2.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, December1, 2009; 1–161.
3.
GoldenMR, SteklerJ, KentJB, HughesJP, WoodRW. An evaluation of HIV partner counseling and referral services using new disposition codes. Sex Transm Dis, 2009; 36:95–101.
4.
GoldenMR, WoodRW, BuskinSE, FlemingM, HarringtonRD. Ongoing risk behavior among persons with HIV in medical care. AIDS Behav, 2007; 11:726–735.
5.
McNuttLA, WuC, XueX, HafnerJP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol, 2003; 157:940–943.
6.
CrepazN, HartTA, MarksG. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA, 2004; 292:224–236.
7.
DonnellD, BaetenJM, KiarieJet al.Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. Lancet, 2010; 375:2092–2098.
8.
KitahataMM, GangeSJ, AbrahamAGet al.Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med, 2009; 360:1815–1826.
9.
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1–infected patients: A collaborative analysis of 18 HIV cohort studies. Lancet, 2009; 373:1352–1363.